Jhaveri Nirav S. has filed 6 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 52500 shares of Opus Genetics, Inc. ($IRD) on March 13, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2025 | Opus Genetics, Inc. | $IRD | Jhaveri Nirav S. | Chief Financial Officer | A | Common Stock | 52500 | $0.00 | 194,293.0000 | 26,715,526 | 37.03% | 0.20% |
| March 13, 2025 | Opus Genetics, Inc. | $IRD | Jhaveri Nirav S. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 52500 | $0.00 | 52,500.0000 | 26,715,526 | 9999.99% | 0.20% |
| Feb. 13, 2025 | Opus Genetics, Inc. | $IRD | Jhaveri Nirav S. | Chief Financial Officer | F | Common Stock | 8207 | $1.15 | 141,793.0000 | 26,715,526 | 5.47% | 0.03% |
| March 21, 2024 | Opus Genetics, Inc. | $IRD | Jhaveri Nirav S. | Chief Financial Officer | P | Common Stock | 10000 | $2.10 | 150,000.0000 | 21,589,821 | 7.14% | 0.05% |
| Feb. 12, 2024 | Opus Genetics, Inc. | $IRD | Jhaveri Nirav S. | Chief Financial Officer | A | Common Stock | 140000 | $0.00 | 140,000.0000 | 21,589,821 | 9999.99% | 0.65% |
| Feb. 12, 2024 | Opus Genetics, Inc. | $IRD | Jhaveri Nirav S. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 210000 | $0.00 | 210,000.0000 | 21,589,821 | 9999.99% | 0.97% |